About the company History Management team and Board Scientific advisors Business Development Career

Technology Platform Pipeline Stem cell therapy Cancer therapy Indications Publications

Share Information Owner List PDMR transactions Financial Calendar Reports Analyses Corporate Governance General Meetings Share Issues Subscribe IR-contact Certified Adviser

Press Releases Xintela in the news Newsletters Events Videos Subscribe Archive

About the company History Management team and Board Scientific advisors Business Development Career GDPR Policy

Technology Platform Pipeline Stem cell therapy Cancer therapy Indications Publications

Share information Owner list PDMR transactions Financial Calendar Reports Analyses Corporate Governance General Meetings Share Issues Subscribe IR-contact Certified Adviser

Press releases Xintela in the news Newsletters Events Videos Subscribe Press photos/logotypes Archive

CONTACT Svenska

Annual General Meeting 2022

Xintela holds its Annual General Meeting on May 6, 2022. Follow the link to read more.

Fullmaktsformulär

Notice of Annual General Meeting 2022

Kallelse årsstämma 2022

ABOUT XINTELA About the company History Management team and Board Scientific advisors Business Development Career possibilities

R&D Technology Platform Pipeline Stem cell therapy Cancer therapy Indications Publications

INVESTORS Extra AGM Share information Owners PDMR transactions Financial Calendar Reports Analyses Corporate Governance Share issue 2020 Subscribe IR contact Certified Adviser

NEWS & MEDIA Press releases Xintela in the news Newsletters Events Films Press photographs Subscribe Archive

Contact xintela ab

Medicon Village
SE-223 81 Lund, Sweden

+46 46 275 65 00

Reg. No: 556780-3480
VAT No: SE556780348001

Visiting address

Scheeletorget 1,
Lund, Sweden

Business & Administration

Evy Lundgren-Åkerlund
CEO
evy@xintela.se

IR & media